This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is closed to new enrollment at this site. This clinical trial is testing a new therapy for a type of cancer known as cutaneous T-cell lymphoma. The treatment involves injections of two types of small proteins known as cytokines: interleukin-12 and interleukin-2.
Showing the most recent 10 out of 459 publications